204 related articles for article (PubMed ID: 30503260)
1. The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.
Salvatori DCF; Dorssers LCJ; Gillis AJM; Perretta G; van Agthoven T; Gomes Fernandes M; Stoop H; Prins JB; Oosterhuis JW; Mummery C; Looijenga LHJ
Stem Cell Reports; 2018 Dec; 11(6):1493-1505. PubMed ID: 30503260
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
4. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.
Ben-David U; Arad G; Weissbein U; Mandefro B; Maimon A; Golan-Lev T; Narwani K; Clark AT; Andrews PW; Benvenisty N; Carlos Biancotti J
Nat Commun; 2014 Sep; 5():4825. PubMed ID: 25198699
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
[TBL] [Abstract][Full Text] [Related]
6. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
[TBL] [Abstract][Full Text] [Related]
7. Humanised Mice and Immunodeficient Mice (NSG) Are Equally Sensitive for Prediction of Stem Cell Malignancy in the Teratoma Assay.
Bialecka M; Montilla-Rojo J; Roelen BAJ; Gillis AJ; Looijenga LHJ; Salvatori DCF
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563071
[TBL] [Abstract][Full Text] [Related]
8. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
9. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
10. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.
Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH
Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas.
Riegler J; Ebert A; Qin X; Shen Q; Wang M; Ameen M; Kodo K; Ong SG; Lee WH; Lee G; Neofytou E; Gold JD; Connolly AJ; Wu JC
Stem Cell Reports; 2016 Feb; 6(2):176-87. PubMed ID: 26777057
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data.
Lobo J; Gillis AJM; van den Berg A; Dorssers LCJ; Belge G; Dieckmann KP; Roest HP; van der Laan LJW; Gietema J; Hamilton RJ; Jerónimo C; Henrique R; Salvatori D; Looijenga LHJ
Cells; 2019 Dec; 8(12):. PubMed ID: 31847394
[TBL] [Abstract][Full Text] [Related]
13. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
[TBL] [Abstract][Full Text] [Related]
14. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
[TBL] [Abstract][Full Text] [Related]
15. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
Murray MJ; Nicholson JC; Coleman N
Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
[TBL] [Abstract][Full Text] [Related]
16. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
[TBL] [Abstract][Full Text] [Related]
17. High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation.
de Souza Lima IM; Schiavinato JLDS; Paulino Leite SB; Sastre D; Bezerra HLO; Sangiorgi B; Corveloni AC; Thomé CH; Faça VM; Covas DT; Zago MA; Giacca M; Mano M; Panepucci RA
Stem Cell Res Ther; 2019 Jul; 10(1):202. PubMed ID: 31287022
[TBL] [Abstract][Full Text] [Related]
18. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.
Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM
Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
20. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
